Higher levels of integration and ingenious power-conversion architectures are enabling simpler, denser, more efficient ...
Eklipsa, a Brand Intelligence System, today issued a formal industry statement asserting that most branding efforts fail not because of poor design, but because branding is treated as a finite ...
The MarketWatch News Department was not involved in the creation of this content. NEW BERLIN, Wis., Jan. 21, 2026 (GLOBE NEWSWIRE) -- What is the difference between a rotary phase converter, a static ...
NEW BERLIN, Wis., Jan. 21, 2026 (GLOBE NEWSWIRE) -- What is the difference between a rotary phase converter, a static phase converter, and a digital phase converter? That’s the question answered in a ...
- EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of ...
VERO BEACH, Fla., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies, today ...
VANCOUVER, British Columbia, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME) a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional ...
Hosted on MSN
BriaCell’s Phase 3 Study in Metastatic Breast Cancer Receives Positive DSMB Recommendation
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from BriaCell ...
ProteinQure, a Toronto-based biotech company pioneering computational peptide drug discovery, today announced the successful dosing of the first patient in its Phase I clinical trial evaluating PQ203 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results